| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.23 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.1 |